Fund profile
Tickers
ETAHX, ETCHX, ETNHX, ETIHX
Fund manager
Total assets
$1.67 bn
Liabilities
$5.50 mm
Net assets
$1.67 bn
Number of holdings
99.00
99 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ZNTL Zentalis Pharmaceuticals Inc | 99.71 mm | 6.58 mm shares | 5.98 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 71.88 mm | 1.81 mm shares | 4.31 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 60.14 mm | 190.00 k shares | 3.61 | Common equity | Long | USA |
US BANK MMDA - USBGFS 9 | 51.80 mm | 51.80 mm principal | 3.11 | Short-term investment vehicle | Long | USA |
AURA Aura Biosciences Inc | 51.41 mm | 5.80 mm shares | 3.08 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 49.24 mm | 4.53 mm shares | 2.95 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 46.42 mm | 556.00 k shares | 2.79 | Common equity | Long | USA |
EVH Evolent Health Inc - Ordinary Shares | 42.90 mm | 1.30 mm shares | 2.57 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 41.84 mm | 565.55 k shares | 2.51 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 39.56 mm | 1.29 mm shares | 2.37 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 38.13 mm | 607.21 k shares | 2.29 | Common equity | Long | USA |
ABMD Abiomed Inc | 37.90 mm | 198.86 k shares | 2.27 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 37.70 mm | 1.06 mm shares | 2.26 | Common equity | Long | USA |
ARGX Argen X SE | 33.73 mm | 88.65 k shares | 2.02 | Common equity | Long | Netherlands |
NARI Inari Medical Inc | 33.30 mm | 512.91 k shares | 2.00 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 32.42 mm | 1.10 mm shares | 1.95 | Common equity | Long | USA |
GH Guardant Health Inc | 31.60 mm | 1.17 mm shares | 1.90 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 28.81 mm | 312.37 k shares | 1.73 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 27.59 mm | 346.71 k shares | 1.66 | Common equity | Long | USA |
LXEO Lexeo Therapeutics Inc. | 27.45 mm | 2.05 mm shares | 1.65 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 27.39 mm | 1.38 mm shares | 1.64 | Common equity | Long | UK |
ARDX Ardelyx Inc | 26.26 mm | 4.24 mm shares | 1.58 | Common equity | Long | USA |
KORRO BIO INC.
|
26.19 mm | 546.33 k shares | 1.57 | Common equity | Long | USA |
IRTC iRhythm Technologies Inc | 25.60 mm | 239.14 k shares | 1.54 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 25.45 mm | 125.09 k shares | 1.53 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 25.34 mm | 809.39 k shares | 1.52 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 23.39 mm | 579.41 k shares | 1.40 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 23.06 mm | 580.00 k shares | 1.38 | Common equity | Long | USA |
PRVA Privia Health Group Inc | 23.03 mm | 1.00 mm shares | 1.38 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 22.62 mm | 763.00 k shares | 1.36 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 22.17 mm | 1.59 mm shares | 1.33 | Common equity | Long | USA |
RGEN Repligen Corp. | 21.40 mm | 119.00 k shares | 1.28 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 20.78 mm | 490.00 k shares | 1.25 | Common equity | Long | USA |
INSM Insmed Inc | 19.68 mm | 635.19 k shares | 1.18 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 17.17 mm | 359.00 k shares | 1.03 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 17.17 mm | 401.10 k shares | 1.03 | Common equity | Long | Virgin Islands (British) |
KRYS Krystal Biotech Inc | 16.93 mm | 136.49 k shares | 1.02 | Common equity | Long | USA |
TMDX Transmedics Group Inc | 16.89 mm | 214.00 k shares | 1.01 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 16.65 mm | 87.00 k shares | 1.00 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 16.44 mm | 1.12 mm shares | 0.99 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 16.18 mm | 445.16 k shares | 0.97 | Common equity | Long | Ireland |
MASS 908 Devices Inc | 16.06 mm | 1.43 mm shares | 0.96 | Common equity | Long | USA |
VCYT Veracyte Inc | 15.52 mm | 564.00 k shares | 0.93 | Common equity | Long | USA |
Avalyn Pharma | 15.00 mm | 20.48 mm shares | 0.90 | Preferred equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 14.71 mm | 490.73 k shares | 0.88 | Common equity | Long | USA |
RCM R1 RCM Inc. | 14.54 mm | 1.38 mm shares | 0.87 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 13.96 mm | 750.00 k shares | 0.84 | Common equity | Long | USA |
INZY Inozyme Pharma Inc | 13.55 mm | 3.18 mm shares | 0.81 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 13.13 mm | 2.23 mm shares | 0.79 | Common equity | Long | USA |
LEXEO THERAPEUTICS
|
12.85 mm | 957.38 k shares | 0.77 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 12.85 mm | 1.14 mm shares | 0.77 | Common equity | Long | Bermuda |
APLS Apellis Pharmaceuticals Inc | 12.56 mm | 209.79 k shares | 0.75 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 11.92 mm | 335.00 k shares | 0.72 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 11.36 mm | 372.67 k shares | 0.68 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 10.35 mm | 361.00 k shares | 0.62 | Common equity | Long | USA |
SHORELINE BIOSCIENCES B | 10.30 mm | 1.49 mm shares | 0.62 | Preferred equity | Long | USA |
SRRK Scholar Rock Holding Corp | 9.87 mm | 525.00 k shares | 0.59 | Common equity | Long | USA |
METAGENOMI LLC | 9.66 mm | 686.72 k shares | 0.58 | Preferred equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 9.59 mm | 313.29 k shares | 0.58 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 9.15 mm | 427.00 k shares | 0.55 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 8.60 mm | 89.22 k shares | 0.52 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 8.47 mm | 740.55 k shares | 0.51 | Common equity | Long | USA |
INCY Incyte Corp. | 7.63 mm | 121.51 k shares | 0.46 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 7.51 mm | 439.47 k shares | 0.45 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 7.11 mm | 261.36 k shares | 0.43 | Common equity | Long | USA |
Freenome Holdings | 7.00 mm | 928.10 k shares | 0.42 | Preferred equity | Long | USA |
BRIDGEBIO PHARMA
|
5.55 mm | 137.51 k shares | 0.33 | Common equity | Long | USA |
BETA BIONIC SERIES B | 5.02 mm | 940.66 k shares | 0.30 | Preferred equity | Long | USA |
RCUS Arcus Biosciences Inc | 4.58 mm | 240.00 k shares | 0.28 | Common equity | Long | USA |
MIRUM PHARMACEUTICALS
|
4.50 mm | 152.38 k shares | 0.27 | Common equity | Long | USA |
BETA BIONICS B2 | 4.39 mm | 809.36 k shares | 0.26 | Preferred equity | Long | USA |
FID-MM GOVT-I | 3.31 mm | 3.31 mm principal | 0.20 | Short-term investment vehicle | Long | USA |
BISPL F 03/12/2025 | 2.82 mm | 2.50 mm principal | 0.17 | Debt | Long | USA |
BETA BIONICS INC SERIES D
|
2.62 mm | 476.19 k shares | 0.16 | Common equity | Long | USA |
Beta Bionics Inc | 2.50 mm | 482.03 k shares | 0.15 | Preferred equity | Long | USA |
FLARE THERAPEUTICS | 2.35 mm | 1.95 mm shares | 0.14 | Preferred equity | Long | USA |
CASMA THERAPEUTI | 1.50 mm | 5.00 mm shares | 0.09 | Preferred equity | Long | USA |
CASMA SER B2 | 1.50 mm | 5.00 mm shares | 0.09 | Preferred equity | Long | USA |
BioSplice Therapeutics | 1.47 mm | 295.28 k shares | 0.09 | Preferred equity | Long | USA |
MetagenomiTechLLC | 1.39 mm | 98.88 k shares | 0.08 | Preferred equity | Long | USA |
BETA BIONICS CL D WARRANT | 1.35 mm | 333.33 k shares | 0.08 | DO | Long | USA |
FLARE THERAPEUTI | 1.32 mm | 1.10 mm shares | 0.08 | Preferred equity | Long | USA |
PELOTON THERAPEU | 1.29 mm | 1.53 mm shares | 0.08 | Preferred equity | Long | USA |
TURNSTD | 1.17 mm | 458.32 k shares | 0.07 | Preferred equity | Long | USA |
Flare Series A Tranche 2 | 1.09 mm | 902.44 k shares | 0.07 | Preferred equity | Long | USA |
PROMETHEUS LABORATORIES | 702.26 k | 1.02 mm shares | 0.04 | Preferred equity | Long | USA |
BETA BIONICS INC SERIES C | 637.45 k | 120.50 k shares | 0.04 | DO | Long | USA |
TSBX Turnstone Biologics Corp | 636.25 k | 250.00 k shares | 0.04 | Common equity | Long | USA |
CASMA THERAPEUTICS | 544.30 k | 1.82 mm shares | 0.03 | Preferred equity | Long | USA |
Kojin Therapeutics | 467.23 k | 763.32 k shares | 0.03 | Preferred equity | Long | USA |
KOJIN THERAPEUTICS INC | 467.23 k | 763.32 k shares | 0.03 | Preferred equity | Long | USA |
CASMA THERAPEUTICS II | 364.48 k | 1.22 mm shares | 0.02 | Preferred equity | Long | USA |
AVTE Aerovate Therapeutics Inc | 275.59 k | 12.18 k shares | 0.02 | Common equity | Long | USA |
ARCH ONCOLOGY IN | 128.80 k | 4.64 mm shares | 0.01 | Preferred equity | Long | USA |
Biosplice Therapeutics | 71.42 k | 72.88 k shares | 0.00 | DO | Long | USA |
FRST AM-GV OB-U | 0.21 | 0.21 principal | 0.00 | Short-term investment vehicle | Long | USA |
GOLDFINCH BIO B2 | 0 | 4.24 mm shares | 0.00 | Preferred equity | Long | USA |
GOLDFINCH BIOPHARMA INC B | 0 | 8.47 mm shares | 0.00 | Preferred equity | Long | USA |
GOLDFINCH BIOPHARMA INC | 0 | 5.00 mm shares | 0.00 | Preferred equity | Long | USA |